How to buy Morphic Holding stock (MORF)

Morphic Holding is a biotechnology business based in the US. Morphic Holding shares (MORF) are listed on the NASDAQ and all prices are listed in US Dollars. Morphic Holding employs 128 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Morphic Holding stock

Buy Morphic Holding stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Morphic Holding stock price (NASDAQ: MORF)

Use our graph to track the performance of MORF stocks over time.

Morphic Holding shares at a glance

• Key figures

Information last updated 2024-10-13.

52-week range	$25.25 - $57.00
50-day moving average more info button	$45.38
200-day moving average more info button	$34.15
Wall St. target price	$56.13
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-3.83

Is it a good time to buy Morphic Holding stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Morphic Holding financials

Gross profit TTM	$-31,254,000
Return on assets TTM	-19.09%
Return on equity TTM	-26.69%
Profit margin	0%
Book value	$12.34
Market Capitalization more info button	$2.9 billion

TTM: trailing 12 months

Morphic Holding share dividends

We're not expecting Morphic Holding to pay a dividend over the next 12 months.

Morphic Holding share price volatility

Over the last 12 months, Morphic Holding's shares have ranged in value from as little as $25.25 up to $57. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Morphic Holding's is 1.49. This would suggest that Morphic Holding's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Morphic Holding overview

Morphic Holding, Inc. , a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. Its lead product candidate MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation is in Phase 2 clinical trials for the treatment of inflammatory bowel disease. The company's products in pipeline include Next Gen a4ß7 Inhibitors for additional potential GI indications, such as EGIDs, pouchitis, etc. ; avß8 for the treatment of Myelofibrosis and solid tumor; and fibronectin integrin for pulmonary hypertensive. In addition, it has a license agreement with Janssen to discover and develop novel integrin therapeutics; collaboration agreement with Schrödinger for integrin targets; and license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. Morphic Holding, Inc.

Frequently asked questions

What percentage of Morphic Holding is owned by insiders or institutions?
Currently 17.129% of Morphic Holding shares are held by insiders and 91.022% by institutions. How many people work for Morphic Holding?
Latest data suggests 128 work at Morphic Holding. When does the fiscal year end for Morphic Holding?
Morphic Holding's fiscal year ends in December. Where is Morphic Holding based?
Morphic Holding's address is: 35 Gatehouse Drive, A2, Waltham, MA, United States, 02451 What is Morphic Holding's ISIN number?
Morphic Holding's international securities identification number is: US61775R1059 What is Morphic Holding's CUSIP number?
Morphic Holding's Committee on Uniform Securities Identification Procedures number is: 61775R105